Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-11-050652
Filing Date
2011-10-05
Accepted
2011-10-05 15:16:54
Documents
1
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c23044_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c23044_4x0.xml 4 4276
  Complete submission text file 0001209191-11-050652.txt   5889
Mailing Address 107 NORTH RYDE SYDNEY C3 1670
Business Address 140 WICKS RD NORTH RYDE NEW SOUTH WALES 2113 C3 2113 01161298780088
NOVOGEN LTD (Reporting) CIK: 0001075880 (see all company filings)

Fiscal Year End: 0630
Type: 4 | Act: 34 | File No.: 000-50484 | Film No.: 111126699
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130 858-792-6300
MARSHALL EDWARDS INC (Issuer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations